GC Green Cross Wellbeing's 'Gujeolcho Extract' Approved as New Dietary Ingredient by US FDA

GC Green Cross Wellbeing logo (Photo by GC Green Cross Wellbeing)

[Asia Economy Reporter Chunhee Lee] GC Green Cross Wellbeing announced on the 18th that its natural ingredient 'Gujeolcho Extract (brand name 'Joincyst')' has received approval as a 'New Dietary Ingredient (NDI)' from the U.S. Food and Drug Administration (FDA).

NDI is a system in which the FDA certifies the safety of an ingredient and grants approval as a new dietary ingredient. 'Gujeolcho Extract' was also recognized as a 'functional ingredient individually approved for health functional foods' by the Korean Ministry of Food and Drug Safety last September.

Gujeolcho Extract is a natural ingredient developed by GC Green Cross Wellbeing. It has been standardized and its safety secured according to guidelines from the Organisation for Economic Co-operation and Development (OECD) and the FDA. Additionally, a human application trial conducted by the orthopedic research team at Inje University Seoul Paik Hospital confirmed its effectiveness in improving joint health in patients with degenerative knee osteoarthritis.

Furthermore, GC Green Cross Wellbeing is currently conducting a project under the Ministry of Trade, Industry and Energy to develop personalized anti-aging materials for joint health based on omics technology. They are carrying out additional clinical studies to research and analyze the biological information and interactions of 'Gujeolcho Extract' and plan to develop personalized health functional foods in the future.

Han Hye-jung, Head of Development at GC Green Cross Wellbeing, said, “This certification is significant as it recognizes the functionality of Gujeolcho in North America, enabling global commercialization,” adding, “We plan to launch the finished product domestically early next year.”

This content was produced with the assistance of AI translation services.